Rising in the East by Petsko, Gregory A
Th   e publication of the complete genome sequence of the 
giant panda, Ailuropoda melanoleuca, is a watershed 
moment for genomics, and not just because of the 
technology used. Before I explain, let me say a few words 
about that technology, because it is worth commenting 
on. Th   e sequence, which was published in the 21 January 
issue of Nature (Li et al., Nature 2010 463:311-317, with 
a nice News and Views piece by Kim Worley and Richard 
Gibbs on pages 303-304; see also the minireview by 
Shaun Jackman and Inanç Birol in Genome Biology
[http://genomebiology.com/2010/11/1/202]), was deter-
mined largely at the Beijing Genomics Institute (more on 
that later), which is not actually in Beijing, but never 
mind. It’s an important genome, in part because the giant 
panda is a highly endangered species (only a few 
thousand are known to exist), in part because on the tree 
of life the panda sits between the human and the dog, but 
also because it is the ﬁ  rst reported mammalian genome 
sequence to be determined using so-called ‘next-
generation’ sequencing methods.
NGS methods, as they are widely called, use machines 
that produce very short sequences at very high speed. 
Compared with more traditional sequencing methodolo-
gies, they also cost much less per base pair. Some tests of 
NGS sequencing have been reported, but none involved 
the de novo assembly of an entire mammalian genome. 
Only the human genome sequence (2001-2003) and the 
mouse genome sequence (2002) have been completed 
with high redundancy and few gaps. Other large 
genomes, such as those of the dog, rat and monkey are 
basically drafts (approximately sevenfold coverage).
Genome sequencing is done in stages. After the 
genome is fragmented, the fragments are sequenced by 
machines that typically read 1,000 bases at a time. Th  e 
reads are assembled by merging overlaps at the ends to 
form continuous sequence fragments (contigs). Traditional 
mammalian genome sequences contain contigs 100 
kilobases long, so that often a complete gene is contained 
in one, providing reasonable accuracy. Contigs are then 
ordered into larger semi-continuous stretches, called 
scaﬀ   olds, using a variety of bioinformatics tools. A 
scaﬀ  old will contain a number of contigs separated by 
gaps. Larger gaps separate the scaﬀ  olds from each other. 
A good draft sequence of a mammalian genome will have 
perhaps a hundred scaﬀ  olds, or even fewer. Some people 
have wondered whether NGS machines, which typically 
read less than 100 bases at a time, would ever give 
comparable accuracy.
Th   e Chinese team has answered that question, with a 
loud aﬃ   rmative. Th  e giant panda sequence has 73-fold 
average redundancy and a median contig length of 
40  kilobases. Th  ose are not typographical errors. Th  e 
high redundancy oﬀ   sets the assembly error problems 
that would compromise the quality of the sequence if the 
coverage were 10-fold or less. However, because of the 
short fragment read length, there are 3,805 scaﬀ  olds. 
Th   at is not a typo either.
Illumina machines were used for most of the sequence, 
and the total cost of the sequencing itself has been 
estimated at less than US$1 million - at least 10 times less 
than that of a comparable genome done by, say, Sanger 
sequencing machines. While we are still a way oﬀ   from 
the $1,000 human genome sequence, the $100,000 
human genome sequence is essentially here.
To me, however, the real import of this paper lies in its 
geographic origin. Th   e Beijing Genomics Institute (BGI) 
has its sequencing facility in Shenzhen, near the border 
with Hong Kong. It is a new but unremarkable building 
whose 11 ﬂ  oors of relatively plain decor belie the state-
of-the-art science going on. It is the brainchild of Yang 
Huanming, a US-trained scientist who founded BGI in 
Beijing in 1999 as a private, non-proﬁ  t research organiza-
tion. Yang quickly got his ﬂ  edgling institute involved in 
China’s contribution to the Human Genome Project. 
Th  ree years later, they made the cover of Science by 
winning the race for the sequence of the rice genome. 
Using Sanger sequencing machines, they completed that 
project in just 74 days. Th  e giant panda sequence took 
6 months.
In 2007, the BGI made two momentous decisions. Th  ey 
made a huge investment in NGS technology, focusing on 
the Illumina Solexa machine, and moved their head-
quarters to Shenzhen. Th   e director is now a home-grown 
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© 2010 BioMed Central Ltdgenome biologist, Jun Wang, who is only 33 years old. He 
is the last of the 123 authors of the giant panda genome 
sequence paper.
Th   e goal of the BGI-Shenzhen is to sequence informa-
tive genomes from all branches of the tree of life. In 2008, 
they completed the sequence of the genome from a Han 
Chinese individual, only the third published complete 
personal human sequence. Th   eir intention is to sequence 
at least 100 more individuals within a few years, to explore 
the enormous ethnic variation in the Chinese population.
Th   e BGI has about 30 Illumina Genome Analyzers, and 
can produce tens of Gigabases of sequence per day. Th  e 
institute is exploring the use of other technologies, such 
as the SOLiD system developed by Life Technologies. It 
has a supercomputer center comprising 500 Linux nodes 
to do the assembly and analysis, and it needs it: the 
sequencing generates 10 terabytes of raw data every 
24  hours. Th  e computer center alone has an annual 
budget of about $9 million; the annual budget of the 
institute is $30 million.
I know what you’re thinking: “I could do the same thing 
here if I had that kind of support from my government.” 
Th   e only problem with that is that you’re mistaken. Th  e 
BGI is a totally private organization, and doesn’t derive a 
single cent of its budget from direct appropriations. It 
exists entirely on competitive contracts and grants, 
income from some spin-oﬀ   companies, plus some private 
donations.
And this is just one institute of many in the exploding 
Chinese scientiﬁ  c landscape. I could instead have told 
you about the National Institute of Biological Sciences in 
Beijing (China’s version of the legendary MRC Laboratory 
of Molecular Biology in Cambridge, UK), where scientists 
have successfully produced fertile mice from induced 
pluripotent stem cells. Or the 10 diﬀ  erent Institutes of 
the Shanghai Institutes for Biological Sciences of the 
Chinese Academy of Sciences, China’s version of the 
intra  mural research program of the National Institutes of 
Health.
But instead, let me tell you about the Kungming 
Institute of Botany, which is located in the capital of 
Yunnan Province, close to Tibet. In addition to doing 
ﬁ  rst-rate botanical work, this institute contains the State 
Key Laboratory of Phytochemistry and Plant Resources 
of West China, which focuses on the search for bioactive 
molecules from natural sources. In this unique research 
facility, teams of chemists screen the vast biodiversity of 
the region and local ethnobotanical knowledge to 
discover compounds that can be developed into new 
drugs for unmet therapeutic needs and agrochemicals 
that do not harm the environment, and then synthesize 
them and make analogs of them. I toured the institute 
with an American synthetic organic chemist, and every 
other poster he would grab my arm, point to something, 
and say, “I’ve never seen anything like that [molecule or 
reaction] before!” In other words, the Kungming Institute 
of Botany, an institute you’ve never heard of in place a 
thousand miles oﬀ   the beaten track, is one of the great 
centers of natural product chemistry in the world.
At a time when the United States is talking about three 
years of level government spending and an anti-
intellectual movement I once thought was fading looks to 
be stronger than ever (more on that next month), China 
is beginning to tap the vast resource of its enormous 
population. Chinese culture has a strong work ethic, the 
government is pouring money into science, higher 
education is trying to emulate that of the United States, 
and living conditions have improved to the point that 
many foreign-trained Chinese scientists are going back 
home instead of remaining abroad permanently. Th  eir 
research system, which is less hierarchical than that of 
Japan or Korea, is much better than either of those two 
countries in allowing young scientists, women as well as 
men, to be independent and advance. I could say 
something as well about the more gradual, but 
nonetheless impressive, rise of science in India, or its 
rapid rise in Singapore. Th  e Far East, once a scientiﬁ  c 
backwater, is becoming a powerhouse.
In 1854 the American Indian Chief Seattle, considering 
whether to sign an unfavorable treaty, uttered these words:
But why should I mourn at the untimely fate of my 
people? Tribe follows tribe, and nation follows nation, like 
the waves of the sea. It is the order of nature, and regret is 
useless. Your time of decay may be distant, but it will 
surely come, for even the White Man whose God walked 
and talked with him as friend to friend, cannot be exempt 
from the common destiny.
I have always believed that not only was he right, but 
that sometime during my lifetime would be the time 
where future historians would draw their imaginary line 
and say, here marks the beginning of the fall of Western 
civilization and the rise of the East. I don’t actually know 
if that’s true, of course, but this much seems certain: 
Western scientiﬁ  c hegemony is fading fast. If you doubt 
it, just look at how many of the interesting and important 
papers in the leading journals are starting to come out of 
China, Korea and Singapore, and still come out of Japan. 
You could start with the 21 January issue of Nature. You 
can’t miss it - it has a pair of giant pandas on the cover.
I feel sorry for those scientists who published other 
papers in that issue. Th   ey probably spent a fair amount of 
time and eﬀ  ort making illustrations they hoped would be 
selected for the cover. Th   ey never had a chance.
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